Literature DB >> 31151960

Modernising vaccine surveillance systems to improve detection of rare or poorly defined adverse events.

Rebecca E Chandler1.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31151960     DOI： 10.1136/bmj.l2268

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Vaccine safety: An evolving evidence-based science.

Authors:  Bruce M McClenathan; Kathryn M Edwards
Journal:  Br J Clin Pharmacol       Date:  2019-08-19       Impact factor: 4.335

Review 2.  Relapse of polymyalgia rheumatica following adjuvanted influenza vaccine: A case-based review.

Authors:  Margaret F Bassendine; Simon H Bridge
Journal:  Eur J Rheumatol       Date:  2019-12-16

3.  Adverse events following measles-mumps-rubella-varicella vaccine: an independent perspective on Italian pharmacovigilance data.

Authors:  Paolo Bellavite; Alberto Donzelli
Journal:  F1000Res       Date:  2020-09-28

4.  Adverse events following COVID-19 vaccination: first 90 days of experience from a tertiary care teaching hospital in South India.

Authors:  Chetak Kadabasal Basavaraja; Juny Sebastian; Mandyam Dhati Ravi; Sheba Baby John
Journal:  Ther Adv Vaccines Immunother       Date:  2021-11-22

5.  Causality assessment of adverse events following immunization: the problem of multifactorial pathology.

Authors:  Paolo Bellavite
Journal:  F1000Res       Date:  2020-03-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.